Ascentage Pharma Group International AAPG
NASDAQ AAPG
$15.24 +0.04 (+0.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Ascentage Pharma Group International (AAPG) Accumulated Expenses (2023 - 2025)

Updated

Ascentage Pharma Group International's Accumulated Expenses came in at $387,216 for Q4 2025, down 81.0% from $2.03 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Accumulated Expenses (2023 - 2025) Analysis & Trends

At the end of FY2025, Ascentage Pharma Group International's Accumulated Expenses was $387,000, down 81.0% from FY2024.

  • Going back by year, Accumulated Expenses was $2.03 million in FY2024 (+253.4%) and $575,489 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Ascentage Pharma Group International 1.42 Bn 382.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 387,215.74
Dec 31, 2024 2.03 Mn
Dec 31, 2023 575,488.95
API Access

Ascentage Pharma Group International Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AAPG&period=max&api_key=YOUR_API_KEY